Multiple solid tumour differentiation marker IVD, kit, enzyme immunoassay (EIA)
United Kingdom·In Vitro Diagnostic Device·Proteomedix AG·Registered Jul 1, 2022- Device ID
- 150728
- MHRA Reference Number
- 150728
- Date Registered
- Jul 1, 2022
- Last Updated
- Dec 22, 2022
- Device Type
- In Vitro Diagnostic Device
- Devices
- Multiple solid tumour differentiation marker IVD, kit, enzyme immunoassay (EIA)
- Type
- IVD General
- Name
- Proteomedix AG
- Address
- Wagistrasse 23 Schlieren, Switzerland
- Created Date
- Jul 1, 2022
- Relationship Type
- UK Responsible Person
- Address
- Compass House, Vision Park Histon c/o Cr360 – UL International Cambridge, England, United KingdomPostcode: CB24 9BZ
Devices with a matching generic name or device type registered with MHRA
Additional devices registered by the same manufacturer
Additional devices represented by Emergo Consulting (UK) Limited in the UK
Multiple solid tumour differentiation marker IVD, kit, enzyme immunoassay (EIA) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 150728. The device is manufactured by Proteomedix AG from Switzerland, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Emergo Consulting (UK) Limited .
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.